Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathogenic Pathways and Therapeutic Strategies in Autosomal Dominant Polycystic Kidney Disease (ADPKD). | J Cell Signal | 2025 | 41608384 | PubTator, text mining | PubMed |
| Relcovaptan: a promising therapeutic agent in traumatic spinal cord injury that acts by modulating newly identified transcriptional regulators of aquaporins compared to tolvaptan. | Turk J Med Sci | 2025 | 41509943 | PubTator, text mining | PubMed |
| Tolvaptan pharmacokinetics and pharmacodynamics in adolescents with autosomal dominant polycystic kidney disease. | Eur J Pediatr | 2025 | 41407907 | PubTator, text mining | PubMed |
| Case Report: One case of pregnancy complicated by large cell neuroendocrine carcinoma of the cervix with syndrome of inappropriate secretion of antidiuretic hormone. | Front Oncol | 2025 | 41395606 | PubTator, text mining | PubMed |
| Type 1 Bartter syndrome presenting as primary diabetes insipidus: a rare Case Report with 8-year follow-up. | Front Genet | 2025 | 41393191 | PubTator, text mining | PubMed |
| Discovery of Non-benzoazacyclic V2R Antagonists for the Treatment of Autosomal Dominant Polycystic Kidney Disease. | J Med Chem | 2025 | 41317118 | PubTator, text mining | PubMed |
| Class A and B GPCRs trigger rapid Gαs translocation to late and slow recycling endosomes. | Commun Biol | 2025 | 41315746 | PubTator, text mining | PubMed |
| The Lysosome Surface is an Unappreciated Hub for Vasopressin V2 Receptor Signaling. | bioRxiv | 2025 | 41256542 | PubTator, text mining | PubMed |
| Kidney stones and autosomal dominant polycystic kidney disease: a state-of-the-art review. | Ren Fail | 2025 | 41208250 | PubTator, text mining | PubMed |
| Clinical outcomes among children with primary nephrogenic diabetes insipidus. | Clin Kidney J | 2025 | 41195290 | PubTator, text mining | PubMed |
| Structural insights into antagonist recognition by the vasopressin V2 receptor. | Nat Commun | 2025 | 41188237 | PubTator, text mining | PubMed |
| Revisiting the Role of Tolvaptan in the Management of Hyponatraemia in Acute Heart Failure: Balancing Quality of Life and Cost With Tolvaptan Treatment. | Cureus | 2025 | 41179034 | PubTator, text mining | PubMed |
| Familial hyponatremia conditioned by the R137C mutation with constitutive activation of the vasopressin receptor. | J Appl Genet | 2025 | 41177862 | PubTator, text mining | PubMed |
| Rickets prevalence and treatment outcome: real-world data from Taiwan. | Clin Exp Pediatr | 2025 | 41132093 | PubTator, text mining | PubMed |
| In silico biological discovery with large perturbation models. | Nat Comput Sci | 2025 | 41094040 | PubTator, text mining | PubMed |
| Late Diagnosis of X-Linked Arginine Vasopressin Resistance Presenting With Flow Uropathy in Adulthood. | JCEM Case Rep | 2025 | 41080977 | PubTator, text mining | PubMed |
| Functional characterization and cAMP-mediated rescue of a novel truncating AVPR2 mutation causing nephrogenic diabetes insipidus. | Am J Physiol Endocrinol Metab | 2025 | 41071673 | PubTator, text mining | PubMed |
| Regulation of aquaporin-2 using traditional Chinese medicine in water balance disorders: a literature review. | Front Cardiovasc Med | 2025 | 41063833 | PubTator, text mining | PubMed |
| Long-Term Effects of Tolvaptan Therapy on Total Kidney Volume and Renal Function in Patients with Autosomal Dominant Polycystic Kidney Disease: A Single-Center Experience. | J Clin Med | 2025 | 41010741 | PubTator, text mining | PubMed |
| Development and interlaboratory validation of a cultivar-specific identification method for the table grape 'Shine Muscat' using loop-mediated isothermal amplification (LAMP). | Breed Sci | 2025 | 41000278 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=4